These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 31513433

  • 21. Pseudomonas aeruginosa suppresses interferon response to rhinovirus infection in cystic fibrosis but not in normal bronchial epithelial cells.
    Chattoraj SS, Ganesan S, Faris A, Comstock A, Lee WM, Sajjan US.
    Infect Immun; 2011 Oct; 79(10):4131-45. PubMed ID: 21825067
    [Abstract] [Full Text] [Related]

  • 22. Increased nuclear suppressor of cytokine signaling 1 in asthmatic bronchial epithelium suppresses rhinovirus induction of innate interferons.
    Gielen V, Sykes A, Zhu J, Chan B, Macintyre J, Regamey N, Kieninger E, Gupta A, Shoemark A, Bossley C, Davies J, Saglani S, Walker P, Nicholson SE, Dalpke AH, Kon OM, Bush A, Johnston SL, Edwards MR.
    J Allergy Clin Immunol; 2015 Jul; 136(1):177-188.e11. PubMed ID: 25630941
    [Abstract] [Full Text] [Related]

  • 23. Neutrophil extracellular traps promote immunopathogenesis of virus-induced COPD exacerbations.
    Katsoulis O, Toussaint M, Jackson MM, Mallia P, Footitt J, Mincham KT, Meyer GFM, Kebadze T, Gilmour A, Long M, Aswani AD, Snelgrove RJ, Johnston SL, Chalmers JD, Singanayagam A.
    Nat Commun; 2024 Jul 09; 15(1):5766. PubMed ID: 38982052
    [Abstract] [Full Text] [Related]

  • 24. Detection of rhinovirus in induced sputum at exacerbation of chronic obstructive pulmonary disease.
    Seemungal TA, Harper-Owen R, Bhowmik A, Jeffries DJ, Wedzicha JA.
    Eur Respir J; 2000 Oct 09; 16(4):677-83. PubMed ID: 11106212
    [Abstract] [Full Text] [Related]

  • 25. A short-term mouse model that reproduces the immunopathological features of rhinovirus-induced exacerbation of COPD.
    Singanayagam A, Glanville N, Walton RP, Aniscenko J, Pearson RM, Pinkerton JW, Horvat JC, Hansbro PM, Bartlett NW, Johnston SL.
    Clin Sci (Lond); 2015 Aug 09; 129(3):245-58. PubMed ID: 25783022
    [Abstract] [Full Text] [Related]

  • 26. Corticosteroid suppression of antiviral immunity increases bacterial loads and mucus production in COPD exacerbations.
    Singanayagam A, Glanville N, Girkin JL, Ching YM, Marcellini A, Porter JD, Toussaint M, Walton RP, Finney LJ, Aniscenko J, Zhu J, Trujillo-Torralbo MB, Calderazzo MA, Grainge C, Loo SL, Veerati PC, Pathinayake PS, Nichol KS, Reid AT, James PL, Solari R, Wark PAB, Knight DA, Moffatt MF, Cookson WO, Edwards MR, Mallia P, Bartlett NW, Johnston SL.
    Nat Commun; 2018 Jun 08; 9(1):2229. PubMed ID: 29884817
    [Abstract] [Full Text] [Related]

  • 27. Inflammatory changes, recovery and recurrence at COPD exacerbation.
    Perera WR, Hurst JR, Wilkinson TM, Sapsford RJ, Müllerova H, Donaldson GC, Wedzicha JA.
    Eur Respir J; 2007 Mar 08; 29(3):527-34. PubMed ID: 17107990
    [Abstract] [Full Text] [Related]

  • 28. Stability of the frequent COPD exacerbator in the general population: A Danish nationwide register-based study.
    Reilev M, Lykkegaard J, Halling A, Vestbo J, Søndergaard J, Pottegård A.
    NPJ Prim Care Respir Med; 2017 Apr 17; 27(1):25. PubMed ID: 28416794
    [Abstract] [Full Text] [Related]

  • 29. Airway IL-1β and Systemic Inflammation as Predictors of Future Exacerbation Risk in Asthma and COPD.
    Fu JJ, McDonald VM, Baines KJ, Gibson PG.
    Chest; 2015 Sep 17; 148(3):618-629. PubMed ID: 25950204
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers?
    Dreyse J, Díaz O, Repetto PB, Morales A, Saldías F, Lisboa C.
    Int J Chron Obstruct Pulmon Dis; 2015 Sep 17; 10():525-33. PubMed ID: 25792820
    [Abstract] [Full Text] [Related]

  • 32. Comparison of innate immune responses towards rhinovirus infection of primary nasal and bronchial epithelial cells.
    Alves MP, Schögler A, Ebener S, Vielle NJ, Casaulta C, Jung A, Moeller A, Geiser T, Regamey N.
    Respirology; 2016 Feb 17; 21(2):304-12. PubMed ID: 26611536
    [Abstract] [Full Text] [Related]

  • 33. Inhibition of phosphodiesterase 4 modulates cytokine induction from toll like receptor activated, but not rhinovirus infected, primary human airway smooth muscle.
    Van Ly D, De Pedro M, James P, Morgan L, Black JL, Burgess JK, Oliver BG.
    Respir Res; 2013 Nov 15; 14(1):127. PubMed ID: 24237854
    [Abstract] [Full Text] [Related]

  • 34. Exacerbations of chronic obstructive pulmonary disease.
    Wedzicha JA, Donaldson GC.
    Respir Care; 2003 Dec 15; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
    [Abstract] [Full Text] [Related]

  • 35. 25-hydroxyvitamin D deficiency, exacerbation frequency and human rhinovirus exacerbations in chronic obstructive pulmonary disease.
    Quint JK, Donaldson GC, Wassef N, Hurst JR, Thomas M, Wedzicha JA.
    BMC Pulm Med; 2012 Jun 22; 12():28. PubMed ID: 22726649
    [Abstract] [Full Text] [Related]

  • 36. Relationship between airway inflammation and the frequency of exacerbations in patients with smoking related COPD.
    Gompertz S, Bayley DL, Hill SL, Stockley RA.
    Thorax; 2001 Jan 22; 56(1):36-41. PubMed ID: 11120902
    [Abstract] [Full Text] [Related]

  • 37. Interferon response of the cystic fibrosis bronchial epithelium to major and minor group rhinovirus infection.
    Schögler A, Stokes AB, Casaulta C, Regamey N, Edwards MR, Johnston SL, Jung A, Moeller A, Geiser T, Alves MP.
    J Cyst Fibros; 2016 May 22; 15(3):332-9. PubMed ID: 26613982
    [Abstract] [Full Text] [Related]

  • 38. Airway gene expression of IL-1 pathway mediators predicts exacerbation risk in obstructive airway disease.
    Baines KJ, Fu JJ, McDonald VM, Gibson PG.
    Int J Chron Obstruct Pulmon Dis; 2017 May 22; 12():541-550. PubMed ID: 28223794
    [Abstract] [Full Text] [Related]

  • 39. "Frequent exacerbator" is a phenotype of poor prognosis in Japanese patients with chronic obstructive pulmonary disease.
    Tomioka R, Kawayama T, Suetomo M, Kinoshita T, Tokunaga Y, Imaoka H, Matsunaga K, Okamoto M, Hoshino T.
    Int J Chron Obstruct Pulmon Dis; 2016 May 22; 11():207-16. PubMed ID: 26893552
    [Abstract] [Full Text] [Related]

  • 40. Cardiovascular risk, myocardial injury, and exacerbations of chronic obstructive pulmonary disease.
    Patel AR, Kowlessar BS, Donaldson GC, Mackay AJ, Singh R, George SN, Garcha DS, Wedzicha JA, Hurst JR.
    Am J Respir Crit Care Med; 2013 Nov 01; 188(9):1091-9. PubMed ID: 24033321
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.